Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Mouth Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cetuximab 2(225)Ac-DOTA-c(RGDyK) 2pembrolizumab 1durvalumab 1atezolizumab 1acetyl-glycyl-asparagyl-glutaminyl-glutamyl-glutaminyl-valyl-seryl-prolyl-leucyl-threonyl-leucyl-leucyl-lysyl-lysyl-tryptophyl-cysteinyl-Alexa Fluoro 680 C2C2-maleimide conjugate 1X-Rays 1Thalidomide 1Standard of Care 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Platinum 1Pilocarpine 1Photons 1Neck Dissection 1Fluorouracil 1Fluorodeoxyglucose F18 1Drug Therapy 1Docetaxel 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Mouth Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated
150 enrolled
Head & Neck

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡